Abstract
Non-typeable Haemophilus influenzae (NTHi) is the most common pathogen in primary ciliary dyskinesia (PCD) patients. We hypothesised that abnormal ciliary motility and low airway nitric oxide (NO) levels on airway epithelial cells from PCD patients might be permissive for NTHi colonisation and biofilm development.
We used a primary epithelial cell co-culture model to investigate NTHi infection. Primary airway epithelial cells from PCD and non-PCD patients were differentiated to ciliation using an air–liquid interface culture and then co-cultured with NTHi.
NTHi adherence was greater on PCD epithelial cells compared to non-PCD cells (p<0.05) and the distribution of NTHi on PCD epithelium showed more aggregated NTHi in biofilms (p<0.001). Apart from defective ciliary motility, PCD cells did not significantly differ from non-PCD epithelial cells in the degree of ciliation and epithelial integrity or in cytokine, LL-37 and NO production. Treatment of PCD epithelia using exogenous NO and antibiotic significantly reduced NTHi viability in biofilms compared with antibiotic treatment alone.
Impaired ciliary function was the primary defect in PCD airway epithelium underlying susceptibility to NTHi biofilm development compared with non-PCD epithelium. Although NO responses were similar, use of targeted NO with antibiotics enhanced killing of NTHi in biofilms, suggesting a novel therapeutic approach.
Abstract
Ex vivo study shows PCD airways risk NTHi biofilm colonisation; novel NO drug overcomes antibiotic tolerance http://ow.ly/GrXC30e4Tqv
Introduction
Motile cilia in the airway contribute to mucociliary clearance (MCC), which is fundamental for protecting the host from respiratory infection. Primary ciliary dyskinesia (PCD) is a genetically heterogeneous condition characterised by abnormal ciliary function with compromised MCC. Patients are characterised by recurrent and chronic sinopulmonary infection, chronic otitis media (OM) and progressive suppurative lung disease from a young age [1].
Non-typeable Haemophilus influenzae (NTHi) is a Gram-negative coccobacillus and, with pneumococcus, the most common bacterial pathogen isolated from the upper and lower respiratory tract of paediatric patients with PCD [2] and chronic OM [3]. NTHi biofilms are present in vivo [4, 5] and ex vivo on adenoid epithelium, or middle ear epithelial biopsies from children with OM [6, 7].
Biofilms are self-organising aggregates of bacteria enveloped in an exopolymeric matrix associated with the respiratory mucosal surface [8−10] and are present in chronic upper and lower respiratory tract infections in OM [6], cystic fibrosis (CF) [11], chronic rhinosinusitis [12] and non-CF bronchiectasis [13]. Biofilm development contributes to the pathophysiology of chronic suppurative respiratory diseases by increasing bacterial recalcitrance to antibiotic therapy and host innate immune responses [14, 15]. Although the effects of abnormal ciliary function on respiratory infections have been studied in animal models of bacteria–virus co-infection [16, 17], bacterial infection has not been widely studied in PCD.
For reasons that are not understood, patients with PCD have low airway nitric oxide (NO) levels compared with non-PCD patients [18, 19]. NO, produced by host epithelial cells and innate immune cells, can be low in response to infection by some respiratory bacteria [20, 21]. We previously observed no difference in the mean NO levels of uninfected primary cultured PCD and non-PCD epithelia, consistent with baseline NO levels reported by others [20, 22]. However, we found PCD epithelial cells significantly increased NO production in response to either stimulation with pro-inflammatory cytokines or to NTHi infection, similar to non-PCD cells [22]. Given the susceptibility of children with PCD to airway infection with NTHi, we hypothesised that epithelial cells from patients with PCD might be permissive for increased NTHi adherence and subsequent biofilm development. To address this hypothesis, we developed a human primary co-culture model using ciliated PCD or non-PCD airway epithelial cells, differentiated at an air–liquid interface (ALI) and infected with a PCD clinical NTHi isolate. In the present study, we used the ALI–epithelial cell NTHi co-culture model [22] to more extensively investigate: 1) airway cell responses to NTHi, including NO production, and 2) the ability of a biofilm-targeted NO donor to augment antibiotic treatment of NTHi.
Materials and methods
Study participants
We recruited 15 patients with a diagnosis of PCD, according to the 2009 European guidelines [23], 10 healthy volunteers and nine patients with respiratory symptoms not caused by PCD (table S1). We have previously published details of the diagnostic methods undertaken at our national PCD Centre [24]. The study gained UK National Health Service Research Ethics approval (06/Q1702/109 and 08/H0502/126) and we obtained written, informed consent.
Culture and biofilm development by clinical NTHi isolates from PCD patients
NTHi isolates from four paediatric PCD patients (HI1–HI4) were subcultured from frozen stocks [25] and verified by Gram stain, V and X diagnostic disc testing, and polymerase chain reaction [6]. NTHi was cultured in brain–heart infusion medium supplemented with haemin and nicotinamide adenine dinucleotide (sBHI) at 37°C to OD600 0.1 (∼2×108 CFU·mL−1 for all strains tested) [25]. Biofilm growth was determined in vitro in triplicate experiments by crystal violet (CV) staining and colony forming unit (CFU) counts on chocolate blood agar (CBA) [26, 27] and by scanning electron microscopy and confocal microscopy using fluorescence in situ hybridisation (FISH) [7, 28].
Epithelial cell and NTHi co-culture model
Detailed information regarding epithelial cell recovery and subsequent analysis is available in the supplementary material and has been published elsewhere. Briefly, primary human nasal epithelial cells were cultured at an ALI until differentiated and ciliated [29, 30]. We used ALI-cultured cells within 1 month. NTHi was co-cultured on the apical surface of epithelial cells from five PCD and nine non-PCD subjects and compared with five non-infected non-PCD controls. We inoculated approximately 1×108 CFU·mL−1 in 500 μL of antibiotic-free ALI medium (multiplicity of infection 100) onto ALI-cultured cells on transwell membranes. Co-cultures were incubated at 37°C/5% CO2 for 72 h with daily medium changes and washed with Hanks' buffered salt solution (HBSS) to remove non-adherent bacteria prior to analyses [25].
Transepithelial electrical resistance (TEER) was measured daily and background subtracted to confirm epithelial integrity (EVOM 2 epithelial voltohmmeter, World Precision Instruments, Sarasota, FL, USA) [31]. Ciliary beat frequency (CBF) and the percentage area of motile to non-motile cilia on ALI-cultured cells before and during NTHi co-culture was measured by whole-field fast Fourier transform analysis (ImageJ https://imagej.net/ with an in-house written plugin) of high-speed video microscopy videos. Briefly, samples were imaged at 37°C using an inverted Olympus IX71 microscope with ×40 objective lens (Olympus, Southend-on-Sea, UK) (1 field=90×95 µm) and a PC2 Photron FASTCAM high-speed video recorded ciliary movement at 250 frames per second [29].
Characterisation of NTHi on ciliated airway cells
Bacteria and epithelial cells were scraped from transwell membranes into sBHI, serially diluted, plated onto CBA and incubated at 37°C/5% CO2 before CFU enumeration (triplicate experiments). We also identified NTHi on ALI culture samples using confocal microscopy by FISH with the Hinf 16S probe [6, 7] and β-tubulin in cilia co-labelled by immunofluorescence [32]. Consecutive fields across the membrane diameter were imaged using an SP5 confocal laser scanning microscope (Leica Microsystems, Milton Keynes, UK) and NTHi volume per field was calculated by Volocity 3D image analysis software (version 6.0.1; PerkinElmer, Coventry, UK). Selected transwell membranes were removed and processed and imaged using an FEI Quanta 200 scanning electron microscope (FEI, Eindhoven, the Netherlands) [25, 28].
Cytokine and LL-37 responses to NTHi infection
Basolateral medium from ALI cultures was frozen before inoculation and then daily following co-culture with NTHi. We measured fibroblast growth factor-β (FGF-β), granulocyte colony-stimulating factor (G-CSF), granulocyte−macrophage colony-stimulating factor (GM-CSF), interleukin-6 (IL-6), interleukin-1 receptor antagonist (IL-1Ra), monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1α (MIP-1α), tumour necrosis factor-α (TNF-α) and vascular endothelial growth factor (VEGF) by fluorokine human multianalyte profiling (MAP) assay with Bio-Plex 200 Analyser detection (R&D systems, Abingdon, UK) in supernatants (50 µL per 96 wells in duplicate) (supplementary material) [33]. Interleukin-8 was measured separately by human IL-8 DuoSet ELISA kit (DY208, R&D systems) and horseradish peroxidase (HRP) substrate was detected by a ThermoMax Microplate Reader (Molecular Devices, Sunnyvale, CA, USA) as per the manufacturer's instructions.
Apical supernatants (100 µL PBS) from ALI-cultured cells were frozen before co-culture and then daily following NTHi inoculation. Samples were dotted onto nitrocellulose membranes and immunolabelled overnight (4°C) with 1:1000 rabbit anti-LL-37 antibody (AB64892; Abcam, Cambridge, UK) followed by 1:10 000 HRP conjugated goat anti-rabbit secondary antibody. After washes, Immuno-star Luminol chemiluminescent substrate was detected using a VersaDoc Imager and quantified by Quantity One v4.6.9 software (Bio-Rad Laboratories, Watford, UK). LL-37 concentrations (duplicate experiments) were compared with a standard curve from serially diluted recombinant LL-37 peptide (AB140725; Abcam).
NO production by airway epithelial cells and treatment with exogenous NO
Transwell membranes of live ALI-cultured epithelial cells were treated with 10 µM 4-amino-5-methylamino-2′,7′-difluorofluorescein diacetate (DAF-FM) to assess the presence of NO [34]. Immunofluorescence labelling was used to localise NO synthase (NOS) (neuronal (nNOS), inducible (iNOS) and endothelial (eNOS) isoenzymes in fixed epithelial cell cultures [32] using confocal microscopy.
ALI-cultured epithelial cell-NTHi co-cultures (72 h) were washed with HBSS to remove non-adherent bacteria [25] and then treated with either 4 mg·mL−1 azithromycin, 50 µM cephalosporin-3ʹ-diazeniumdiolate NO donor prodrug PYRRO-C3D, or with a combination of both azithromycin and PYRRO-C3D for 2 h. All treatments were prepared in HBSS with 1% DMSO (also used as the untreated control), and NTHi CFUs were enumerated on CBA as above (n=4) [25].
Statistical methods
The t-test and Mann–Whitney U-test were performed using Graphpad Prism software (version 6.0a, 2012, Graphpad Software, Inc.). The Sidak–Bonferroni method was used to adapt p-values for multiple comparison t-tests. p<0.05 demonstrated statistical significance.
Results
Study participants
Demographic and clinical details of the 15 PCD and 19 non-PCD participants are presented in table 1. All PCD patients exhibited abnormal ciliary function (table S1).
Biofilm development by clinical NTHi isolates from PCD patients
We assessed the ability of four PCD NTHi isolates to form biofilms by standard assays (CV, CFU counts) and by scanning electron microscopy and confocal microscopy using the Hinf-specific 16S FISH probe (supplementary material) (figure 1). Clinical isolates (HI3 and HI4), from children who repeatedly cultured NTHi over 4 years, demonstrated biofilm development with significantly greater CV staining of exopolymeric matrix compared with isolates from children culturing NTHi for the first time (HI1 and HI2) (figure 1a). However, CFU counts were not significantly different between isolates (figure 1b). Isolate HI4 was used for future experiments.
Epithelial cell and NTHi co-culture
NTHi adhered to ciliated airway epithelial cells from both PCD and non-PCD patients. At 72 h, however, there was significantly more viable NTHi 3.8×106 CFUs (±7.5×105) on PCD epithelia compared with 2.0×106 CFUs (±4.8×105) on non-PCD epithelia (p<0.05) (figure 2a), in agreement with scanning electron microscopy data (figure 2c, d). PCD cells harboured discrete adherent aggregates of bacterial cells (biofilms) (figure 2c) in contrast to the singularly distributed NTHi bacterial cells on non-PCD epithelial cells (figure 2d).
We imaged co-cultures by confocal microscopy using a combination of FISH to label NTHi and an anti-β-tubulin antibody to label cilia. Orthogonal section image analysis of confocal microscope Z-stacks showed that the mean±sem NTHi biomass volume (per field of view) was four times greater on PCD ALI-cultured epithelia (710±150 μm3) than non-PCD primary cell ALI cultures (160±20 μm3) (p<0.001) (figure 2b). Aggregated NTHi were evident in biofilms on PCD primary cell epithelia that had dysfunctional or static cilia (figure 2e). In contrast there was less NTHi labelling on non-PCD epithelia with normally functioning cilia (figure 2f).
PCD cells showed either static (n=4) or slow dyskinetic (n=1) cilia. The CBF of non-PCD epithelial cells remained within normal ranges (11–20 Hz) throughout the 72 h of NTHi co-culture, indicating that NTHi did not impair ciliary motility (figure 3a). Ciliation of ALI-cultured epithelial cells was similar in PCD and non-PCD, as observed by light microscopy and scanning electron microscopy (figure 3b). The percentage area of motile cilia per field of view on non-PCD ALI-cultured cells did not change during the co-culture period on non-PCD airway cells (figure 3c). TEER was used to measure epithelial cell barrier function before and after apical NTHi inoculation onto ciliated ALI-cultured primary airway cells. The TEER plateau reached prior to NTHi infection was the same for PCD and non-PCD cells and was maintained for 72 h in co-culture, demonstrating epithelial integrity (p-values ranged from 0.35 to 0.93) (figure 3d).
Cytokine and LL-37 responses to NTHi infection
The mean±SEM concentration of cationic LL-37 peptide secreted from epithelial cell ALI-cultures peaked 24 h following NTHi inoculation, where an 8.8±2.9-fold increase in PCD and 3.8±0.6-fold increase in non-PCD samples was observed, but values remained within group variation at baseline and after inoculation (figure 4a, b). The levels of FGF-β, G-CSF, GM-CSF, VEGF or IL-1Ra, IL-6, IL-8, MCP-1, MIP-1α and TNF-α in basolateral medium from PCD or non-PCD cells, sampled before or daily during 72 h of NTHi co-culture (figure 4c) did not significantly differ, indicating that PCD airway cells produced cytokines and chemokines similarly to non-PCD cells. These data indicate that PCD and non-PCD epithelial cells produce similar defence responses to NTHi.
NO production by airway epithelial cells and treatment with exogenous NO
Airway levels of NO are extremely low in patients with PCD [18, 19]. However, we found using immunofluorescence labelling of epithelial cells that the nNOS, iNOS and eNOS isoenzymes are present in both ciliated PCD and non-PCD cells (figure 5). Additionally, we detected NO in PCD and non-PCD ALI culture samples using DAF-FM, which strongly fluoresces in the presence of NO (figure 5).
We have previously shown that NO modulates NTHi metabolism in vitro [25]. Therefore, we tested if exogenous NO treatment impacted NTHi growing on ciliated PCD epithelial cells. Epithelial cell-NTHi co-cultures were treated with the cephalosporin-3ʹ-diazeniumdiolate NO donor prodrug, PYRRO-C3D, which releases NO following activation by β-lactamases [25]. We found that 4 mg·mL−1 azithromycin treatment, which is in excess of the planktonic minimum inhibitory concentration (1 μg·mL−1), failed to kill biofilm NTHi on PCD epithelial cells. In contrast, when PYRRO-C3D was used alongside azithromycin, NTHi viability decreased nearly 3 logs (figure 6). These results suggest that NTHi in biofilms on PCD ciliated epithelial cells are tolerant of antibiotic treatment and that tolerance was abrogated by β-lactamase-mediated delivery of NO from the prodrug to NTHi.
Discussion
Our principal finding was that NTHi formed adherent biofilms on ALI-cultured PCD ciliated airway cells significantly more than on non-PCD controls over 72 h of co-culture, with the only attributable difference being ciliary dysfunction of PCD samples. Since host–pathogen interactions have not been widely studied in the context of PCD, these results are novel. NTHi is prevalent in PCD and other diseases in children associated with impaired mucociliary clearance, such as CF [35] and chronic OM [36]. NTHi biofilm development features in the pathophysiology of chronic or recurrent respiratory infections in both CF and chronic OM [6, 4, 13], but little is known about NTHi infection in PCD. We hypothesised that abnormal ciliary motility on airway epithelial cells from PCD patients might be permissive for NTHi colonisation and biofilm development. To our knowledge, our polarised airway epithelial ALI culture infection model is the first to examine the effects of NTHi on primary ciliated airway cells from PCD patients and non-PCD donors. Biofilm development was previously demonstrated with NTHi isolates from young CF patients using Calu-3 cell co-cultures [11]. However, because Calu-3 cells do not ciliate, this model did not assess the role of cilia in NTHi adherence and biofilm development [37].
We compared PCD and non-PCD epithelial cell responses, including secreted inflammatory and antimicrobial proteins and epithelial integrity, ciliation and ciliary function following NTHi co-culture. Cytokine production, including pro-inflammatory cytokines and chemokines involved in leukocyte recruitment, and secreted levels of the antimicrobial peptide LL-37, were commensurable between PCD and non-PCD co-cultures. Epithelial integrity was also comparable in airway epithelial cells co-cultured with NTHi. Although all PCD ALI-cultured epithelial cells had dysfunctional ciliary movement, in contrast to the normally functioning non-PCD epithelial cells (table S1), the total ciliation pre-infection was similar, as demonstrated by scanning electron microscopy and immunofluorescent labelling of β-tubulin on cilia using confocal microscopy. Importantly, NTHi infection did not adversely affect normal ciliary function (CBF and percentage area of motile cilia) on non-PCD ALI-cultured airway cells over the experimental period. Taken together, we found the only difference between PCD and non-PCD was in ciliary motility, supporting the hypothesis that abnormal ciliary function in PCD increases the risk of NTHi biofilm development.
PCD patients exhibit abnormally low airway (particularly nasal) NO levels, the causes of which are still being debated [18]. Previously it was found that ALI-cultured PCD primary epithelial cells fail to increase NO levels early after infection with S. pneumoniae, suggesting that NO biosynthesis and iNOS induction was abnormal in PCD epithelial cells [20]. In contrast, the work herein extends our previous study and demonstrates that NO biosynthesis is similar in PCD and non-PCD epithelial cells, both constitutively and following NTHi infection [22]. We have now also assessed NO levels using complementary methods and show that PCD and non-PCD cells exhibit similar NO biosynthesis and NOS isoenzyme expression that co-localises with the cilia marker β-tubulin, during co-culture. These studies support our previous data showing that PCD epithelial cells are capable of biosynthesising NO. Primary epithelial cell NO responses may, however, vary with the type of bacteria, and notably the PCD NTHi isolate did not induce the cytotoxic effects observed with S. pneumoniae [38].
Our results indicate that NTHi is present in matrix-enclosed aggregates adherent to polarised ciliated PCD epithelial cells [8]. Biofilm development is well known to reduce the efficacy of antibiotic therapy. Our data indicate that NTHi biofilms on airway epithelial cell cultures were tolerant of azithromycin treatment that easily kills planktonic NTHi [25], as it was ineffective in reducing NTHi viability. In contrast, co-administration of azithromycin with the novel pro-drug PYRRO-C3D, designed to target NO release specifically to bacteria following β-lactamase activation, reduced NTHi viability by nearly 3 logs on PCD epithelial cells. These results support recent studies with S. pneumoniae [28] and NTHi [25] showing that NO plays a role in modulating metabolic activity in these respiratory bacteria, resulting in increased antibiotic sensitivity. Importantly, our airway epithelial cell co-culture model permitted the translational investigation of anti-NTHi biofilm treatments in a physiologically relevant context with human primary cells. These results suggest that adjunctive exogenous NO therapy administered in combination with antibiotics to treat infections warrants further investigation.
This study has some limitations. First, because PCD cases are rare (≈1:10 000), the co-culture experiments are challenging to replicate in high numbers. Secondly, we examined a limited number of clinical NTHi isolates in co-cultures. Thirdly, our studies focused on epithelial cells and did not investigate other innate cell responses that are important in host defences to NTHi, or may contribute to disease progression. Despite these limitations, our studies suggest that NTHi biofilms play a role in the chronicity of respiratory infections in PCD and provide hypothesis-driven research questions for further work assessing mechanisms of pathogenesis.
In summary, this study reports key observations regarding NTHi infection of primary ciliated epithelial cells from PCD patients. Firstly, abnormal ciliary function in PCD appears to be more permissive for NTHi biofilm development than non-PCD airway cells that have normal motility. Secondly, ALI-cultured primary airway cells from PCD patients appear to be competent in several defensive responses following NTHi infection, exhibiting comparable cytokine and LL-37 production with non-PCD airway cells. Thirdly, although nasal NO levels are abnormally low in most cases of PCD, ALI-cultured airway cells from PCD patients produced similar levels of NO following NTHi co-culture compared with non-PCD cells. Fourthly, this study demonstrates that our co-culture model provided a robust assay to investigate anti-infective treatments. Finally, we show that targeted exogenous NO enhanced antibiotic killing of NTHi in biofilms growing on PCD epithelia, suggesting a novel therapeutic approach for NTHi infection in PCD.
Supplementary material
Supplementary Material
Please note: supplementary material is not edited by the Editorial Office, and is uploaded as it has been supplied by the author.
Supplementary methods ERJ-00612-2017_Supplement
Supplementary table S1 ERJ-00612-2017_Supplementary_table
Disclosures
Supplementary Material
S.N. Faust ERJ-00612-2017_Faust
M.J. Kelso ERJ-00612-2017_Kelso
J.S.A. Lucas ERJ-00612-2017_Lucas
Acknowledgements
We would like to thank Anton Page and Patricia Goggin, Biomedical Imaging Unit, University of Southampton, for their advice and help with electron microscopy techniques. We would also like to thank James Thompson and Janice Coles for their help and support with cell culturing and the patients who provided nasal brushing samples obtained from our Primary Ciliary Dyskinesia Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Footnotes
This article has supplementary material available from erj.ersjournals.com
Support statement: The National PCD Centre at UHS is commissioned and funded by NHS England. PCD research in Southampton is supported by NIHR Southampton Respiratory Biomedical Research Unit and the Southampton NIHR Wellcome Trust Clinical Research Facility. W.T. Walker, C.L. Jackson, S.A. Collins, J.S.A. Lucas and L. Hall-Stoodley are participants in COST Action BEAT-PCD (BM1407). M.J. Kelso acknowledges funding from the Australian Cystic Fibrosis Research Trust (ACFRT). Funding information for this article has been deposited with the Crossref Funder Registry.
Conflict of interest: Disclosures can be found alongside this article at erj.ersjournals.com
- Received March 23, 2017.
- Accepted June 4, 2017.
- Copyright ©ERS 2017